Observational study characterizes treatment persistence and burden in adults with focal onset seizures, indicating unmet needs.
To characterize epilepsy burden and unmet needs associated with ASM use through patient-reported data from the EMPOWER study and real-world claims data from adults with focal onset seizures (FOS).
No takes yet. Share an insight, caveat, or question.
Gazdag et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: